Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.45 |
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5107799 | 0.83 | CYP3A4 (0.48) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL1373616 | 0.82 | CYP3A4 (0.52) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL12533057 | 0.79 | CYP3A4 (0.45) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL775188 | 0.79 | CYP3A4 (0.54) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL1154758 | 0.78 | IDO1 (0.50) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL29493203 | 0.78 | IDO1 (0.50) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL775187 | 0.77 | CYP3A4 (0.52) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL6055610 | 0.77 | CYP3A4 (0.52) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL3786384 | 0.77 | CYP3A4 (0.52) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL11737566 | 0.77 | CYP3A4 (0.46) | CYP3A4ALOX15SMN1; SMN2TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119098205-A | Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof | 南京理工大学 | 2024-12-10 | — | — | CN | claimed |
| CN-109180661-A | The chloro- 2-(thienyl -2- base of 6-) quinazoline synthetic method | 郑州大学 | 2019-01-11 | — | — | CN | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| CN-1284773-C | Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application | BAIRUI GLOBAL CO LTD (VG) | 2006-11-15 | — | — | CN | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| CN-1477099-A | O-pyridinoquinone derivative, composition containing the same, preparation method and use of the same | 百瑞全球有限公司 | 2004-02-25 | — | — | CN | claimed |
| US-6509393-B2 | Phase change inks | XEROX CORPORATION | 2003-01-21 | — | — | US | claimed |
| US-20020137816-A1 | Phase change inks | XEROX CORPORATION | 2002-09-26 | — | — | US | claimed |
| CN-121159410-A | Preparation method of 2-amino-5-chlorobenzenemethanol | 枣阳市福星化工有限公司 | 2025-12-19 | — | — | CN | disclosed |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | UNIVERSITY OF MARYLAND, COLLEGE PARK (US) | 2025-07-01 | — | — | US | disclosed |
| CN-116375641-B | C3-phenoxy substituted quinoline compound and synthetic method and application thereof | 杭州师范大学 | 2025-01-03 | — | — | CN | disclosed |
| CN-119098205-A | Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof | 南京理工大学 | 2024-12-10 | — | — | CN | disclosed |
| US-20240199612-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | SHIRE HUMAN GENETIC THERAPIES (US) | 2024-06-20 | — | — | US | disclosed |
| EP-4308227-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | Takeda Pharmaceutical Company Limited (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-4268510-A | DEMETHANIZATION, METABOLISM, RUMEN | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1981-05-19 | — | — | US | disclosed |
| US-4214889-A | Benzoxazine herbicides | SANDOZ, INC. (US) | 1980-07-29 | — | — | US | disclosed |
| EP-0010348-A1 | Heterocyclic trichloromethyl derivatives, process for their preparation and their use | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-04-30 | — | — | EP | disclosed |
| US-4164407-A | Benzoxazine herbicides | SANDOZ, INC. (US) | 1979-08-14 | — | — | US | disclosed |
| US-4002621-A | 6-Chloro-2-(3,4-dichloroanilino)-4H-3,1-benzothiazine | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-01-11 | — | — | US | disclosed |
| US-4002620-A | 2-Anilino-4H-3,1-benzothiazines | MORTON-NORWICH PRODUCTS, INC. (US) | 1977-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | CYP3A4 32/4885ALOX15 227/4885SMN1; SMN2 3704/4885 |
| US-20240199612-A1 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | KLKB1, KLK1, KLK4 | CYP3A4 975/4885ALOX15 4285/4885SMN1; SMN2 4781/4885 |
| US-12344571-B1 | Organic color center-tailored, semiconducting carbon nanotubes and their method of manufacture | NOS1, NOS3, NOS2 | CYP3A4 1460/4885ALOX15 1639/4885SMN1; SMN2 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.